The Effectiveness of Mindfulness-Based Stress Reduction on Mental Health and Salivary cortisol and a-amylase

Not Applicable

Conditions: Condition 1: Anxiety. Condition 2: Depression.
Other anxiety disorders
Other depressive episodes
F41:
F32.8

Registration Number: IRCT20190927044898N1

Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 30

Inclusion Criteria

Score above 14 on the Depression and Anxiety subscales and above 18 on the Stress subscale of the Stress of DASS-21
The age range of 18 to 25
Sign the ethical consent
Minimum education of reading and writing

Exclusion Criteria

Existence or history of severe psychiatric disorder
Smoking and psychotropic pills
Use of psychiatric drugs
Epilepsy
Various cardiovascular and respiratory and blood pressure disorders
Aspirin use a acetaminophen over the past 48 hours
A history of cancer
Diabetes
Hypothyroidism or hyperthyroidism
Addison, cushing's and cushing's syndrome, hypertension, corticosteroid and steroid medications.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improve mental health. Timepoint: The subjects of the two groups will complete the DASS-21 and GHQ-28 questionnaires in the pre-test and post-test phases. Method of measurement: Stress, Anxiety and Depression Scale (DASS-21) and General Health Questionnaire (GHQ-28).;Decreased levels of cortisol and alpha-amylase. Timepoint: Saliva collection in this study was done in two stages: pre-test (before the intervention and during rest) and post-test (after the intervention). Method of measurement: To collect saliva samples, the participants are asked to passively collect their secreted saliva for 5 minutes in designated tubes.

Secondary Outcome Measures